Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Ellis

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
American Heart Journal|March 31, 1999
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarctionD Hasdai, A Lerman, C S Rihal, et al.
The New England Journal of Medicine|July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting InvestigatorsA M Lincoff, R M Califf, D J Moliterno, et al.
The American Journal of Cardiology|December 14, 2001
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary interventionM T Roe, C B Granger, J A Puma, et al.
Circulation|July 1, 1997
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventionsC Simpfendorfer, K Kottke-Marchant, M Lowrie, et al.
Circulation|January 11, 2000
Effect of intracoronary gamma-radiation therapy on in-stent restenosis: An intravascular ultrasound analysis from the gamma-1 studyG S Mintz, N J Weissman, P S Teirstein, et al.
Journal of the American College of Cardiology|April 1, 1997
Bailout and corrective use of Gianturco-Roubin flex stents after percutaneous transluminal coronary angioplasty: operator reports and angiographic core laboratory verification from the National Heart, Lung, and Blood Institute/New Approaches to Coronary Intervention RegistryL S Dean, C J George, G S Roubin, et al.
The American Journal of Cardiology|October 6, 2000
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockadeF A Cura, S R Kapadia, P L L'Allier, et al.
The American Journal of Cardiology|March 11, 1999
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trialW S Weintraub, S D Culler, A Kosinski, et al.
Circulation|December 24, 1997
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996S G Ellis, H Tamai, M Nobuyoshi, et al.
Circulation|February 18, 1997
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI InvestigatorsE M Ohman, N S Kleiman, G Gacioch, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
American Heart Journal|March 31, 1999
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarctionD Hasdai, A Lerman, C S Rihal, et al.
The New England Journal of Medicine|July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting InvestigatorsA M Lincoff, R M Califf, D J Moliterno, et al.
The American Journal of Cardiology|December 14, 2001
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary interventionM T Roe, C B Granger, J A Puma, et al.
Circulation|July 1, 1997
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventionsC Simpfendorfer, K Kottke-Marchant, M Lowrie, et al.
Circulation|January 11, 2000
Effect of intracoronary gamma-radiation therapy on in-stent restenosis: An intravascular ultrasound analysis from the gamma-1 studyG S Mintz, N J Weissman, P S Teirstein, et al.
Journal of the American College of Cardiology|April 1, 1997
Bailout and corrective use of Gianturco-Roubin flex stents after percutaneous transluminal coronary angioplasty: operator reports and angiographic core laboratory verification from the National Heart, Lung, and Blood Institute/New Approaches to Coronary Intervention RegistryL S Dean, C J George, G S Roubin, et al.
The American Journal of Cardiology|October 6, 2000
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockadeF A Cura, S R Kapadia, P L L'Allier, et al.
The American Journal of Cardiology|March 11, 1999
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trialW S Weintraub, S D Culler, A Kosinski, et al.
Circulation|December 24, 1997
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996S G Ellis, H Tamai, M Nobuyoshi, et al.
Circulation|February 18, 1997
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI InvestigatorsE M Ohman, N S Kleiman, G Gacioch, et al.
Pageof 23